176 related articles for article (PubMed ID: 17407134)
1. Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.
Tefferi A; Huang J; Schwager S; Li CY; Wu W; Pardanani A; Mesa RA
Cancer; 2007 May; 109(10):2083-8. PubMed ID: 17407134
[TBL] [Abstract][Full Text] [Related]
2. Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
Elliott MA; Verstovsek S; Dingli D; Schwager SM; Mesa RA; Li CY; Tefferi A
Leuk Res; 2007 Nov; 31(11):1503-9. PubMed ID: 17397921
[TBL] [Abstract][Full Text] [Related]
3. Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system.
Dingli D; Schwager SM; Mesa RA; Li CY; Tefferi A
Cancer; 2006 Feb; 106(3):623-30. PubMed ID: 16369987
[TBL] [Abstract][Full Text] [Related]
4. Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival.
Patnaik MM; Caramazza D; Gangat N; Hanson CA; Pardanani A; Tefferi A
Eur J Haematol; 2010 Feb; 84(2):105-8. PubMed ID: 19895568
[TBL] [Abstract][Full Text] [Related]
5. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
Hussein K; Huang J; Lasho T; Pardanani A; Mesa RA; Williamson CM; Ketterling RP; Hanson CA; Van Dyke DL; Tefferi A
Eur J Haematol; 2009 Apr; 82(4):255-9. PubMed ID: 19215287
[TBL] [Abstract][Full Text] [Related]
6. Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.
Leitch HA; Chase JM; Goodman TA; Ezzat H; Rollins MD; Wong DH; Badawi M; Leger CS; Ramadan KM; Barnett MJ; Foltz LM; Vickars LM
Hematol Oncol; 2010 Mar; 28(1):40-8. PubMed ID: 19557769
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognostic factors in primary myelofibrosis patients under 45 years old].
Lu L; Xiao ZJ; Chen HS; Lin H; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):281-4. PubMed ID: 15949290
[TBL] [Abstract][Full Text] [Related]
8. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for leukemic transformation in patients with primary myelofibrosis.
Huang J; Li CY; Mesa RA; Wu W; Hanson CA; Pardanani A; Tefferi A
Cancer; 2008 Jun; 112(12):2726-32. PubMed ID: 18404742
[TBL] [Abstract][Full Text] [Related]
10. Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.
Pardanani A; Finke C; Abdelrahman RA; Lasho TL; Tefferi A
Am J Hematol; 2013 Apr; 88(4):312-6. PubMed ID: 23450619
[TBL] [Abstract][Full Text] [Related]
11. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
[TBL] [Abstract][Full Text] [Related]
12. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.
Sagaster V; Jäger E; Weltermann A; Schwarzinger I; Gisslinger H; Lechner K; Geissler K; Oehler L
Haematologica; 2003 Nov; 88(11):1204-12. PubMed ID: 14607748
[TBL] [Abstract][Full Text] [Related]
13. Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal.
Breccia M; Latagliata R; Cannella L; Carmosino I; De Cuia R; Frustaci A; Stefanizzi C; Santopietro M; Alimena G
Leuk Res; 2009 Mar; 33(3):391-4. PubMed ID: 18676015
[TBL] [Abstract][Full Text] [Related]
14. Survival probabilities of Pugh-Child-PBC classified patients in the euricterus primary biliary cirrhosis population, based on the Mayo clinic prognostic model. Euricterus Project Management Group.
Reisman Y; van Dam GM; Gips CH; Lavelle SM; Euricterus PM
Hepatogastroenterology; 1997; 44(16):982-9. PubMed ID: 9261586
[TBL] [Abstract][Full Text] [Related]
15. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Tefferi A; Dingli D; Li CY; Dewald GW
Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients.
Arora B; Sirhan S; Hoyer JD; Mesa RA; Tefferi A
Br J Haematol; 2005 Jan; 128(1):42-8. PubMed ID: 15606548
[TBL] [Abstract][Full Text] [Related]
17. [Primary myelofibrosis: description of a series of 53 patients].
Pereira A; Cervantes F; Montserrat E; Rozman C
Med Clin (Barc); 1989 Apr; 92(14):521-5. PubMed ID: 2666765
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
19. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Ruggeri M; Rodeghiero F; d'Amore ES; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Antonioli E; Carrai V; Gisslinger H; Buxhofer-Ausch V; Müllauer L; Carobbio A; Gianatti A; Gangat N; Hanson CA; Tefferi A
J Clin Oncol; 2011 Aug; 29(23):3179-84. PubMed ID: 21747083
[TBL] [Abstract][Full Text] [Related]
20. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
Trivanović D; Petkovic M; Stimac D
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]